1195 - F-18 Flurodeoxyglucose Positron Emission Tomography (FDG PET) for the diagnosis of Alzheimer's Disease

Page last updated: 11 July 2016

Application Detail

Status

Closed

Description of Medical Service

FDG is a slightly radioactive form of glucose that can be safely injected into a patient. After 30 minutes a scan can then be performed with a PET camera, which takes approximately 15 minutes.

Description of Medical Condition

Alzheimer’s disease is the most common cause of dementia. It is progressive and leads to severe disability and then morbidity – on average seven years from diagnosis. Symptoms of Alzheimer’s disease are present for several years before diagnosis and the pathological process that leads to the dementia of Alzheimer’s disease begins a decade or more before diagnosis.

Reason for Application

-

Medical Service Type

-

Previous Application Number

Not Applicable

Associated Documentation

Application Form

-

PICO Confirmation

23 June 2014 - 18 July 2014
Consultation Protocol (PDF 338 KB)
Consultation Protocol (Word 103 KB)

Feedback and Survey
Application Feedback and Survey (PDF 44 KB)
Application Feedback and Survey (Word 91 KB)

Final Protocol (PDF 270 KB)
Final Protocol (Word 96 KB)

Assessment Report

Assessment Report (PDF 896 KB)
Assessment Report (Word 838 KB)

Public Summary Document

Public Summary Document (PDF 205 KB)
Public Summary Document (Word 294 KB)

Meetings for this Application

PASC

16 to 17 April 2014
14 to 15 August 2014

ESC

12 to 13 February 2015

MSAC

1 to 2 April 2015